5 October 2015

Oxford PharmaGenesis release balloons to raise awareness of Duchenne muscular dystrophy

Duchenne muscular dystrophy (DMD) is a progressive and ultimately fatal genetic muscle wasting disease that affects approximately 1 in 3500 newborn boys.1 A fault in the dystrophin gene prevents the production of the protein dystrophin, which is important for muscle structure and function. Continue reading

23 September 2015

Oxford PharmaGenesis Basel office expansion featured in Director magazine

The experieDirectornce and insights of Oxford PharmaGenesis into founding its office in Basel are highlighted in a feature in the September issue of Director magazine (the publication of the UK Institute of Directors).

The feature focuses on UK company expansion into Switzerland and includes quotes from an interview with Dr Richard White, Commercial Director of Oxford PharmaGenesis and a member of the Institute of Directors. Continue reading

18 September 2015

Oxford PharmaGenesis celebratesJeans for Genes Day 2015

[vc_row][vc_column width=”1/1″][vc_column_text]Today, employees at Oxford PharmaGenesis wore their jeans to support Jeans for Genes Day, helping to raise vital funds for children and families affected by genetic disorders.

A ‘Bling my Jeans’ competition was held, which was adjudicated while staff enjoyed a delicious ‘all you can eat’ breakfast buffet. Continue reading

3 August 2015

Oxford PharmaGenesis raises money for VICTA (Visually Impaired Children Taking Action) at Prudential RideLondon-Surrey 100

VH.facebook_1438590779090Commercial Director of Oxford PharmaGenesis, Richard White, has completed the Prudential RideLondon-Surrey 100 cycle race to raise funds for VICTA (Visually Impaired Children Taking Action), a charity that supports blind and partially sighted children in the UK. Oxford PharmaGenesis matches donations raised by employees in events that support health-related causes. Continue reading

24 July 2015

Oxford PharmaGenesis delivers global webinar on best practice in the publication and communication of Real World Evidence

Nearly 200 medical communications and pharma industry professionals worldwide tuned in yesterday to hear Oxford PharmaGenesis deliver a webinar on publication and communication of Real World Evidence (RWE). Commercial Director Richard White and Account Director Tim Koder presented the webinar as part the International Society of Medical Publications Professionals (ISMPP) online educational series, ISMPP University (ISMPP U). Continue reading

15 July 2015

Oxford PharmaGenesis goes to Buckingham Palace

QA_Palace_DSC_0020 (2)Managing Director Chris Winchester and Commercial Director Richard White are proud to have represented Oxford PharmaGenesis as a winner of the Queen’s Awards for Enterprise 2015 at a reception at Buckingham Palace last night.

The reception, hosted by the Queen and the Duke of Edinburgh, was attended by the Duke of York, Princess Eugenie of York, the Princess Royal, the Duke of Gloucester, the Duke of Kent, Princess Michael of Kent and Princess Alexandra as well as the other winners of this year’s Awards.

Chris Winchester says, “It has been a great honour to meet the Queen and other members of the Royal Family and to celebrate the achievements of all 139 companies who have won the Queen’s Awards 2015.”

Richard White comments, “It is exciting to see other bioscience companies – including some based in Oxford, such as Zinc Ahead and Isis Innovation – represented in the Queen’s Awards this year. This is great news for our sector.”

Chris and Richard will be attending the UK Trade and Investment South East’s lunch for Queen’s Awards winners later today.


1 23 24 25 26 27 31